Clinical trial
Results of Phase III Study to Assess if Zoledronic Acid Have Antumor Activity in Multiple Myeloma
NCT01234129 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Results of Phase III Study to Assess if Zoledronic Acid Have Antumor Activity in Multiple Myeloma
- Lead sponsor
- Instituto Mexicano del Seguro Social
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- December 31, 2009
- Enrollment
- 320 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.